Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia

American Journal of Neuroradiology

Volumn 21, Issue 7, 2000, Pages 1184-1189

  Schellinger, P D ^a   Jansen, O ^a   Fiebach, J B ^a   Pohlers, O ^a   Ryssel, H ^a   Heiland, S ^a   Steiner, T ^a   Hacke, W ^a   Sartor, K ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; FEASIBILITY STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SAFETY; STROKE;

ADULT; AGED; AGED, 80 AND OVER; CEREBRAL INFARCTION; DIFFUSION; ECHO-PLANAR IMAGING; FEASIBILITY STUDIES; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; THROMBOLYTIC THERAPY; TIME AND MOTION STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033842034     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. MR imaging of intravoxel incoherent motions: Application to diffusion and perfusion in neurologic disorders
2. Anisotropy in diffusion-weighted MRI
3. Diffusion-weighted MR imaging of acute stroke: Correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats
4. Comparison of diffusion- and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats
5. Fast magnetic resonance diffusion-weighted imaging of acute human stroke
6. Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke
7. Pitfalls and potential of clinical diffusion-weighted MR imaging in acute stroke
8. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: A preliminary analysis
9. Hyperacute stroke: Evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging
10. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome
11. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI
12. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke
13. Clinical experience with diffusion-weighted MR in patients with acute stroke
14. Diffusion-weighted MR imaging: Diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset
15. Early recanalization in acute ischemic stroke saves tissue at risk defined by MRI
16. Evaluation of early reperfusion and IV rt-PA therapy using diffusion- and perfusion-weighted MRI
17. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
18. Detection of hyperacute primary intraparenchymal hemorrhage by magnetic resonance imaging
19. A standardized MRI stroke protocol: Comparison with CT in hyperacute intracerebral hemorrhage
20. Magnetic resonance imaging in acute stroke: Not ready for prime time
21. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging
22. Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window
23. Longitudinal MRI study of perfusion and diffusion in stroke: Evolution of lesion volume and correlation with clinical outcome
24. Diffusion-weighted magnetic resonance imaging: An ECG for 'brain attack'?
25. Diffusion MRI for evaluating cerebrovascular disease
26. Magnetic resonance versus computed tomographic imaging in acute stroke
27. New reasons for early use of MRI in stroke
28. Advances in clinical neuroradiology
29. Neuroradiological diagnosis in acute ischemic stroke. Value of modern techniques
30. Diffusion MRI in patients with transient ischemic attacks
31. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke?
32. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: A randomized controlled trial
33. Multimodal MRI in hyperacute ischemic stroke: Associations of tissue at risk, vessel occlusion, recanalization, morphological and functional outcome
34. Optimizing intensive care in stroke: A European perspective- A report of an ad hoc consensus group meeting
35. European strategies for early intervention in stroke. A report of an ad hoc consensus group meeting
36. Expanding the window for thrombolytic therapy in acute stroke - The potential role of acute MRI for patient selection
37. Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra
38. Hyperacute stroke: Ultra-fast MR imaging to triage patients prior to therapy